loadpatents
Patent applications and USPTO patent grants for Ankersen; Michael.The latest application filed is for "aryl carbonyl derivatives as therapeutic agents".
Patent | Date |
---|---|
Aryl carbonyl derivatives as therapeutic agents Grant RE45,670 - Polisetti , et al. September 15, 2 | 2015-09-15 |
Heteroaryl-ureas and their use as glucokinase activators Grant RE45,183 - Murray , et al. October 7, 2 | 2014-10-07 |
Heteroaryl-ureas and their use as glucokinase activators Grant 8,263,634 - Murray , et al. September 11, 2 | 2012-09-11 |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes Grant 8,148,413 - Lau , et al. April 3, 2 | 2012-04-03 |
Aryl Carbonyl Derivatives As Therapeutic Agents App 20110301158 - Polisetti; Dharma Rao ;   et al. | 2011-12-08 |
Aryl carbonyl derivatives as therapeutic agents Grant 8,063,081 - Polisetti , et al. November 22, 2 | 2011-11-22 |
N-heteroaryl Indole Carboxamides And Analogues Thereof, For Use As Glucokinase Activators In The Treatment Of Diabetes App 20110082144 - Lau; Jesper F. ;   et al. | 2011-04-07 |
Heteroaryl-ureas And Their Use As Glucokinase Activators App 20110060019 - Murray; Anthony ;   et al. | 2011-03-10 |
Aryl carbonyl derivatives as therapeutic agents Grant 7,897,628 - Polisetti , et al. March 1, 2 | 2011-03-01 |
Heteroaryl-ureas and their use as glucokinase activators Grant 7,872,139 - Murray , et al. January 18, 2 | 2011-01-18 |
Heteroaryl-ureas and their use as glucokinase activators Grant 7,851,636 - Murray , et al. December 14, 2 | 2010-12-14 |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes Grant 7,812,043 - Lau , et al. October 12, 2 | 2010-10-12 |
Heteroaryl-Ureas and Their Use as Glucokinase Activators App 20100204288 - Murray; Anthony ;   et al. | 2010-08-12 |
Heteroaryl-ureas and their use as glucokinase activators Grant 7,598,391 - Murray , et al. October 6, 2 | 2009-10-06 |
Heteroaryl-Ureas and Their Use as Glucokinase Activators App 20090216013 - Murray; Anthony ;   et al. | 2009-08-27 |
Compounds with growth hormone releasing properties Grant 7,576,062 - Peschke , et al. August 18, 2 | 2009-08-18 |
Aryl carbonyl derivatives as therapeutic agents Grant 7,541,373 - Polisetti , et al. June 2, 2 | 2009-06-02 |
Peptides for use in treating obesity Grant 7,541,430 - Sensfuss , et al. June 2, 2 | 2009-06-02 |
Peptides for Use In Treating Obesity App 20090088388 - Sensfuss; Ulrich ;   et al. | 2009-04-02 |
Aryl carbonyl derivatives as therapeutic agents Grant 7,384,967 - Polisetti , et al. June 10, 2 | 2008-06-10 |
Aryl carbonyl derivatives as therapeutic agents App 20080119454 - Polisetti; Dharma Rao ;   et al. | 2008-05-22 |
Aryl carbonyl derivatives as therapeutic agents App 20080119455 - Polisetti; Dharma Rao ;   et al. | 2008-05-22 |
Peptides for use in treating obesity App 20070244054 - Sensfuss; Ulrich ;   et al. | 2007-10-18 |
Compounds and compositions for treating obesity App 20070185128 - Conde-Frieboes; Kilian Waldemar ;   et al. | 2007-08-09 |
Heteroaryl-ureas and their use as glucokinase activators App 20070054897 - Murray; Anthony ;   et al. | 2007-03-08 |
N-heteroaryl indole carboxamides and analogues thereof, for use as glcokinase activators in the treatment of diabetes App 20070027140 - Lau; Jesper F. ;   et al. | 2007-02-01 |
Aryl carbonyl derivatives as therapeutic agents App 20060183783 - Polisetti; Dharma Rao ;   et al. | 2006-08-17 |
Compounds with growth hormone releasing properties App 20050233981 - Peschke, Bernd ;   et al. | 2005-10-20 |
Compounds with growth hormone releasing properties Grant 6,939,880 - Hansen , et al. September 6, 2 | 2005-09-06 |
Compounds with growth hormone releasing properties Grant 6,919,315 - Peschke , et al. July 19, 2 | 2005-07-19 |
Aryl carbonyl derivatives as therapeutic agents App 20040122235 - Polisetti, Dharma Rao ;   et al. | 2004-06-24 |
Compound with growth hormone releasing properties Grant 6,576,648 - Ankersen June 10, 2 | 2003-06-10 |
Compounds with growth hormone releasing properties Grant 6,555,570 - Hansen , et al. April 29, 2 | 2003-04-29 |
Compounds with growth hormone releasing properties App 20030055261 - Hansen, Thomas Kruse ;   et al. | 2003-03-20 |
Compounds with growth hormone releasing properties App 20030040483 - Hansen, Thomas Kruse ;   et al. | 2003-02-27 |
Compositions for the treatment of the catabolic state of prolonged critical illness App 20020160961 - Ankersen, Michael | 2002-10-31 |
Compound with growth hormone releasing properties App 20010041720 - Ankersen, Michael | 2001-11-15 |
Compounds with growth hormone releasing properties Grant 6,303,620 - Hansen , et al. October 16, 2 | 2001-10-16 |
Compounds with growth hormone releasing properties Grant 6,274,584 - Peschke , et al. August 14, 2 | 2001-08-14 |
Use of somatostatin agonists and antagonists for treating diseases related to the eye Grant 6,159,941 - Ankersen , et al. December 12, 2 | 2000-12-12 |
Compounds with growth hormone releasing properties Grant 6,127,341 - Hansen , et al. October 3, 2 | 2000-10-03 |
Compounds with growth hormone releasing properties Grant 6,127,391 - Hansen , et al. October 3, 2 | 2000-10-03 |
Somatostatin agonists and antagonists Grant 6,127,343 - Ankersen , et al. October 3, 2 | 2000-10-03 |
Compounds with growth hormone releasing properties Grant 6,127,354 - Peschke , et al. October 3, 2 | 2000-10-03 |
Compounds with growth hormone releasing properties Grant 6,013,658 - Lau , et al. January 11, 2 | 2000-01-11 |
Compounds with growth hormone releasing properties Grant 5,977,178 - Hansen , et al. November 2, 1 | 1999-11-02 |
Compounds with growth hormone releasing properties Grant 5,922,770 - Peschke , et al. July 13, 1 | 1999-07-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.